 <h1>Obagi Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>tretinoin topical</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about tretinoin topical. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Obagi.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to tretinoin topical: topical cream, topical gel/jelly, topical lotion</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, tretinoin topical (the active ingredient contained in Obagi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking tretinoin topical:</p><p>
<i>More common</i>
</p><ul>
<li>Burning, stinging, peeling, redness, or unusual dryness of the skin (severe)</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Dryness, pain, redness, irritation, or peeling at the application site</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of tretinoin topical may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Burning, itching, stinging, scaling, or redness of the skin</li>
<li>chapping or slight peeling of the skin (mild)</li>
<li>darkening of the skin</li>
<li>lightening of normal skin color</li>
<li>lightening of treated areas of dark skin</li>
<li>redness of skin (mild)</li>
<li>unusual dryness of skin (mild)</li>
<li>unusually warm skin (mild)</li>
</ul><p>
<!-- end topical cream, topical gel/jelly, topical lotion --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tretinoin topical: topical cream, topical gel, topical kit, topical liquid, topical lotion</i></p><h3>Dermatologic</h3><p>Cream:</p>
<p><b>Very common</b> (10% or more): Severe skin irritation (Up to 32%)</p>
<p><b>Frequency not reported</b>: Mild irritation, peeling/skin exfoliation, erythema, pruritus, blistering, pain, crusting, tenderness, dry skin, burning/warmth/stinging, photosensitivity/increased sensitivity to light</p>
<p><b>Postmarketing reports</b>: Temporary hyper/hypopigmentation, rash, skin atrophy</p>
<p></p>
<p>Gel:</p>
<p><b>Very common</b> (10% or more): Dry skin (Up to 16%), peeling/scaling/flaking skin (Up to 12%)</p>
<p><b>Common</b> (1% to 10%): Burning sensation, erythema, pruritus, skin pain, sunburn</p>
<p><b>Frequency not reported</b>: Blistering/crusting skin</p>
<p><b>Postmarketing reports</b>: Temporary hypo/hyperpigmentation, increased susceptibility to sunlight</p>
<p></p>
<p>Microsphere Gel:</p>
<p><b>Common</b> (1% to 10%): Skin irritation, skin burning, erythema, dermatitis</p>
<p><b>Frequency not reported</b>: Peeling, dryness, stinging, itching</p>
<p><b>Postmarketing reports</b>: Temporary hypo/hyperpigmentation<sup>[Ref]</sup></p><p>Erythema, peeling, dryness, burning/stinging, and/or itching occurred most frequently during the first 2 weeks of therapy.</p>
<p></p>
<p>Most of the dermatologic side effects were mild in severity (approximately 63%), and approximately 34% were of moderate severity.</p>
<p></p>
<p>Dry, peeling, scaling, and/or flaking skin occurred most often in the gel formulation.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Cream:</p>
<p><b>Frequency not reported</b>: Reversible liver function test changes (bilirubin, alkaline phosphatase, ALT, AST)<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Cream:</p>
<p><b>Frequency not reported</b>: Thymol turbidity elevations, increased flocculation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cream:</p>
<p><b>Postmarketing reports</b>: Edema/swelling of application site<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Cream:</p>
<p><b>Frequency not reported</b>: Allergic contact dermatitis</p>
<p><b>Postmarketing reports</b>: Allergic reaction<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Retin-A (tretinoin)." Ortho Pharmaceutical Corporation, Raritan, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Renova (tretinoin topical)." Janssen Pharmaceuticals, Titusville, NJ. </p><p id="ref_4">4. "Product Information. Avita (tretinoin topical)." Penederm Inc, Foster City, CA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Obagi (tretinoin topical)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: topical acne agents</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Retin-A, Renova, Atralin, Altreno, ... +5 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Acne</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tretinoin topical: topical cream, topical gel, topical kit, topical liquid, topical lotion</i></p><h3>Dermatologic</h3><p>Cream:</p><p><b>Very common</b> (10% or more): Severe skin irritation (Up to 32%)</p><p><b>Frequency not reported</b>: Mild irritation, peeling/skin exfoliation, erythema, pruritus, blistering, pain, crusting, tenderness, dry skin, burning/warmth/stinging, photosensitivity/increased sensitivity to light</p><p><b>Postmarketing reports</b>: Temporary hyper/hypopigmentation, rash, skin atrophy</p><p></p><p>Gel:</p><p><b>Very common</b> (10% or more): Dry skin (Up to 16%), peeling/scaling/flaking skin (Up to 12%)</p><p><b>Common</b> (1% to 10%): Burning sensation, erythema, pruritus, skin pain, sunburn</p><p><b>Frequency not reported</b>: Blistering/crusting skin</p><p><b>Postmarketing reports</b>: Temporary hypo/hyperpigmentation, increased susceptibility to sunlight</p><p></p><p>Microsphere Gel:</p><p><b>Common</b> (1% to 10%): Skin irritation, skin burning, erythema, dermatitis</p><p><b>Frequency not reported</b>: Peeling, dryness, stinging, itching</p><p><b>Postmarketing reports</b>: Temporary hypo/hyperpigmentation<sup>[Ref]</sup></p><p>Erythema, peeling, dryness, burning/stinging, and/or itching occurred most frequently during the first 2 weeks of therapy.</p><p></p><p>Most of the dermatologic side effects were mild in severity (approximately 63%), and approximately 34% were of moderate severity.</p><p></p><p>Dry, peeling, scaling, and/or flaking skin occurred most often in the gel formulation.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Cream:</p><p><b>Frequency not reported</b>: Reversible liver function test changes (bilirubin, alkaline phosphatase, ALT, AST)<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Cream:</p><p><b>Frequency not reported</b>: Thymol turbidity elevations, increased flocculation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cream:</p><p><b>Postmarketing reports</b>: Edema/swelling of application site<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Cream:</p><p><b>Frequency not reported</b>: Allergic contact dermatitis</p><p><b>Postmarketing reports</b>: Allergic reaction<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Retin-A (tretinoin)." Ortho Pharmaceutical Corporation, Raritan, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Renova (tretinoin topical)." Janssen Pharmaceuticals, Titusville, NJ. </p><p id="ref_4">4. "Product Information. Avita (tretinoin topical)." Penederm Inc, Foster City, CA. </p><h2>More about Obagi (tretinoin topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: topical acne agents</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Acne</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>